Remove Community Pharmacies Remove Hospitals Remove Omnicell
article thumbnail

In the Face of Resistance, 340B Coalition Summer Conference Proves Program’s Worth

Omnicell

To date, we've seen 18 pharmaceutical manufacturers, including Johnson & Johnson, Novartis, and Merck, impose unilateral restrictions on 340B discounts when drugs are dispensed at community pharmacies. Omnicell can be a valued partner in this effort. “However, this is becoming more difficult as restrictions increase.

article thumbnail

Time for Congress to Break the Contract Pharmacy Logjam

Omnicell

Ted Slafsky Founder and Principal, Wexford Solutions, and Publisher and CEO, 340B Report As of publication time, eight pharmaceutical manufacturers either have stopped offering or placed significant restrictions on 340B discounts when a provider contracts with a retail or community pharmacy to dispense medicines.